Cover Image
市場調查報告書

全球脊椎生技藥品市場預測(2016∼2026年):脫鈣骨基質、BMP/生長因子、人工骨骼替代物、細胞基礎基材、加工骨、同類移植骨、血小板濃縮設備、傳統融合、體內融合

Global Spine Biologics Market Forecast 2016-2026: Demineralized Bone Matrix, BMP/Growth Factor, Bone Substitutes, Cell Based Matrices, Machined Bone, Allograft Bone, Platelet Concentrators, Traditional Fusion, Interbody Fusion

出版商 Visiongain Ltd 商品編碼 410422
出版日期 內容資訊 英文 142 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球脊椎生技藥品市場預測(2016∼2026年):脫鈣骨基質、BMP/生長因子、人工骨骼替代物、細胞基礎基材、加工骨、同類移植骨、血小板濃縮設備、傳統融合、體內融合 Global Spine Biologics Market Forecast 2016-2026: Demineralized Bone Matrix, BMP/Growth Factor, Bone Substitutes, Cell Based Matrices, Machined Bone, Allograft Bone, Platelet Concentrators, Traditional Fusion, Interbody Fusion
出版日期: 2016年11月25日 內容資訊: 英文 142 Pages
簡介

全球脊椎生技藥品市場預計從2015年的29億9,700萬美元到2020年擴大到38億9,900萬美元。

本報告提供全球脊椎生技藥品市場相關調查,市場概要和至2026年的預測,收益趨勢,各產品趨勢,各國趨勢,及進入此市場的主要企業簡介等彙整資料。

第1章 本報告概要

第2章全球脊椎生技藥品市場簡介

  • 市場結構
  • 市場定義
  • 次市場定義
    • 脫鈣骨基質
    • BMP/生長因子
    • 人工骨骼替代物
    • 細胞基礎基材
    • 加工骨
    • 同類移植骨
  • 法律規章

第3章 全球脊椎生技藥品市場:2016∼2026年

  • 市場預測
  • 推動市場因素和阻礙因素

第4章 各產品市場

  • 簡介
  • 脫鈣骨基質
  • BMP/生長因子
  • 人工骨骼替代物
  • 細胞基礎基材
  • 加工骨
  • 同類移植骨
  • 血小板濃縮設備
  • 其他

第5章 各手術類型市場

  • 簡介
  • 傳統融合市場
  • 體內融合市場

第6章 各終端用戶市場

  • 簡介
  • 住院外科脊椎中心
  • 門診外科脊椎中心

第7章 各國市場

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第8章 主要企業

  • 脊椎生技藥品
  • Medtronic plc
  • SeaSpine Holdings Corporation
  • DePuy Synthes (a business segment of Johnson & Johnson)
  • Stryker Corporation
  • GLOBUS MEDICAL, INC.
  • Zimmer Biomet Holdings, Inc.
  • NuVasive, Inc.
  • Alphatec Holdings, Inc.

第9章 SWOT分析

第10章 結論與建議

圖表

目錄
Product Code: PHA0153

Title:
GLOBAL SPINE BIOLOGICS MARKET FORECAST 2016-2026
Demineralized Bone Matrix, BMP/Growth Factor, Bone Substitutes, Cell Based Matrices, Machined Bone, Allograft Bone, Platelet Concentrators, Traditional Fusion, Interbody Fusion, Inpatient and Outpatient Surgery Centers.

The global Spine Biologics market is expected to grow at a moderate single digit growth rate over the forecast period. The global spine biologics market was valued at $2,997m in 2015. Visiongain forecasts this market to increase to $3,899m in 2020. The market will then continue to increase to $5,604m in 2026, growing at a CAGR 6.2% between 2020 and 2026.

How this report will benefit you:

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 142-page report you will receive 125 in-depth charts - all unavailable elsewhere.

The 142 page report provides clear detailed insight into the global spine biologics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Spine Biologics market forecasts from 2016-2026
  • Spine biologics national market forecasts from 2016-2026, covering:
    • United States
    • Canada
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
    • Rest of the World
  • Spine Biologics submarket forecasts from 2016-2026 covering:
  • Revenue forecasts to 2026 are provided for the following segments in the spine biologics market, by product:
    • Demineralized Bone Matrix
    • BMP/Growth Factor
    • Bone Substitutes
    • Cell Based Matrices
    • Machined Bone
    • Allograft Bone
    • Platelet Concentrators
  • Revenue forecasts to 2026 are provided for the following segments in the spine biologics market, by type of surgery:
    • Traditional Fusion
    • Interbody Fusion
  • Revenue forecasts to 2026 are provided for the following segments in the spine biologics market, by end user:
    • Inpatient Surgery Centers
    • Outpatient Surgery Centers
  • Analysis of the key factors driving growth in the global, regional and country level of spine biologics market from 2016-2026
  • Assesses selected leading companies, examining recent performance and outlooks.
  • Assessment of leading companies in the spine biologics market as well as strengths, weaknesses, opportunities, and threats in the market.

Visiongain's study is intended for anyone requiring commercial analyses for the Spine Biologics Market and leading companies. You find data, trends and predictions.

Buy our report today Global Spine Biologics Market Forecast 2016-2026: Demineralized Bone Matrix, BMP/Growth Factor, Bone Substitutes, Cell Based Matrices, Machined Bone, Allograft Bone, Platelet Concentrators, Traditional Fusion, Interbody Fusion, Inpatient and Outpatient Surgery Centers.

visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Spine Biologics Market Overview
  • 1.2. Why You Should Read This Report
  • 1.3. How This Report Delivers
  • 1.4. Who is This Report For?
  • 1.5. Methodology
    • 1.5.1. Primary Research
    • 1.5.2. Secondary Research
    • 1.5.3. Market Evaluation & Forecasting Methodology
  • 1.6. Frequently Asked Questions (FAQ)
  • 1.7. Associated Visiongain Reports
  • 1.8. About Visiongain

2. Introduction to the Global Spine Biologics Market

  • 2.1. Global Spine Biologics Market Structure
  • 2.2. Spine Biologics Market Definition
  • 2.3. Spine Biologics Submarkets Definition
    • 2.3.1. Demineralized Bone Matrix Submarket Definition
    • 2.3.2. BMP/Growth Factors Submarket Definition
    • 2.3.3. Bone Substitutes Submarket Definition
    • 2.3.4. Cell Based Matrices Submarket Definition
    • 2.3.5. Machined Bones Submarket Definition
    • 2.3.6. Allograft Bones Submarket Definition
  • 2.4. Regulations for Biologics

3. Global Spine Biologics Market 2016-2026

  • 3.1. Global Spine Biologics Market Forecast 2016-2026
  • 3.2. Global Spine Biologics Drivers & Restraints 2016

4. Spine Biologics Market by Product 2016-2026

  • 4.1. Introduction
  • 4.2. Demineralized Bone Matrix (DBM) Market 2016-2026
  • 4.3. BMP/Growth Factors Market 2016-2026
  • 4.4. Bone Substitutes Market 2016-2026
  • 4.5. Cell Based Matrices Market 2016-2026
  • 4.6. Machined Bone Market 2016-2026
  • 4.7. Allograft Bone Market 2016-2026
  • 4.8. Platelet Concentrators Market 2016-2026
  • 4.9. Other Spine Biologics Market 2016-2026

5. Spine Biologics Market by Type of Surgery 2016-2026

  • 5.1. Introduction
  • 5.2. Traditional Fusion Market 2016-2026
  • 5.3. Interbody Fusion Market 2016-2026

6. Spine Biologics Market by End Users 2016-2026

  • 6.1. Introduction
  • 6.2. Inpatient Surgery Spine Centers 2016-2026
  • 6.3. Outpatient Surgery Spine Centers 2016-2026

7. Leading National Markets 2016-2026

  • 7.1. Introduction
  • 7.2. North America Spine Biologics Market 2016-2026
    • 7.2.1. U.S. Spine Biologics Market 2016-2026
    • 7.2.2. Canada Spine Biologics Market 2016-2026
  • 7.3. Europe Spine Biologics Market 2016-2026
    • 7.3.1. Germany Spine Biologics Market 2016-2026
    • 7.3.2. U.K. Spine Biologics Market 2016-2026
    • 7.3.3. France Spine Biologics Market 2016-2026
    • 7.3.4. Italy Spine Biologics Market 2016-2026
    • 7.3.5. Spain Spine Biologics Market 2016-2026
    • 7.3.6. Russia Spine Biologics Market 2016-2026
    • 7.3.7. Rest of Europe Spine Biologics Market 2016-2026
  • 7.4. Asia-Pacific Spine Biologics Market 2016-2026
    • 7.4.1. Japan Spine Biologics Market 2016-2026
    • 7.4.2. China Spine Biologics Market 2016-2026
    • 7.4.3. India Spine Biologics Market 2016-2026
    • 7.4.4. Australia Spine Biologics Market 2016-2026
    • 7.4.5. Rest of Asia-Pacific Spine Biologics Market 2016-2026
  • 7.5. Rest of the World (RoW) Spine Biologics Market 2016-2026

8. Leading Companies in the Spine Biologics Market, 2016-2026

  • 8.1. Spine Biologics:
  • 8.2. Medtronic plc
    • 8.2.1. Medtronic Product Portfolio, 2015
    • 8.2.2. Medtronic plc: Historical and Performance Analysis
    • 8.2.3. Medtronic plc: Recent Developments
      • 8.2.3.1. U.S. FDA Approval - Infuse Bone Graft
      • 8.2.3.2. Acquistion of Osteotech Inc.
  • 8.3. SeaSpine Holdings Corporation
    • 8.3.1. SeaSpine Product Portfolio, 2015
    • 8.3.2. SeaSpine: Historical and Performance Analysis
    • 8.3.3. SeaSpine Holdings Corporation: Recent Developments
  • 8.4. DePuy Synthes (a business segment of Johnson & Johnson)
    • 8.4.1. DePuy Synthes: Product Portfolio, 2015
    • 8.4.2. JOHNSON & JOHNSON: Historical and Performance Analysis
    • 8.4.3. DePuy Synthes: Recent Developments
      • 8.4.3.1. Introduction of VIVIGEN CELLULAR BONE MATRIX
      • 8.4.3.2. Agreement with LifeNet Health (U.S.)
      • 8.4.3.3. Launched New Tissue Implant-CONFORM SHEET
  • 8.5. Stryker Corporation
    • 8.5.1. Stryker Corporation Product Portfolio, 2015
    • 8.5.2. Stryker Corporation: Historical and Performance Analysis
    • 8.5.3. Stryker Corporation: Recent Developments
      • 8.5.3.1. Introduction of Next Generation Viable Bone Matrix
      • 8.5.3.2. Strategic Partnership with Osiris
      • 8.5.3.3. Accellos' Warehouse Management System
      • 8.5.3.4. Acqusition of Orthovita Inc
  • 8.6. GLOBUS MEDICAL, INC.
    • 8.6.1. GLOBUS MEDICAL, INC.Product Portfolio, 2015
    • 8.6.2. GLOBUS MEDICAL, INC.: Historical and Performance Analysis
    • 8.6.3. GLOBUS MEDICAL, INC.: Recent Developments
      • 8.6.3.1. Acquistion of Alphatec's International Business
      • 8.6.3.2. Acquistion of Transplant Technologies of Texas, Ltd. (TTOT)
  • 8.7. Zimmer Biomet Holdings, Inc.
    • 8.7.1. Zimmer Biomet Holdings, Inc.Product Portfolio, 2015
    • 8.7.2. Zimmer Biomet Holdings, Inc.: Historical and Performance Analysis
    • 8.7.3. Zimmer Biomet Holdings, Inc.: Recent Developments
      • 8.7.3.1. Distribution Agreement with CelgenTek Innovations Corporation
      • 8.7.3.2. Acquistion Biomet, Inc.
  • 8.8. NuVasive, Inc.
    • 8.8.1. NuVasive Inc.Product Portfolio, 2015
    • 8.8.2. NuVasive, Inc.: Historical and Performance Analysis
    • 8.8.3. NuVasive, Inc.: Recent Developments
      • 8.8.3.1. Launch of Next Generation Biologics Technology
  • 8.9. Alphatec Holdings, Inc.
    • 8.9.1. Alphatec Holdings, Inc..Product Portfolio, 2015
    • 8.9.2. Alphatec Holdings, Inc.: Historical and Performance Analysis
    • 8.9.3. Alphatec Holdings, Inc.: Recent Developments
      • 8.9.3.1. Launch of Neocore(TM) Osteoconductive Matrix

9. SWOT Analysis of the Spine Biologics Market

  • 9.1. Strengths
    • 9.1.1. Evolving Regulatory Framework
    • 9.1.2. Technological Innovations in Biomaterials
    • 9.1.3. Initiatives and Supports from the Governments
  • 9.2. Weaknesses
    • 9.2.1. The High Cost of Spine Biologics Products
    • 9.2.2. Lack of Funding from Venture Capital
    • 9.2.3. Lack of Standardisation in Manufacturing Process
    • 9.2.4. New Business Models are yet to be Established
  • 9.3. Opportunities
    • 9.3.1. Development of 3D Printed Bone Grafts and Other Innovative Technology
    • 9.3.2. Rising Trend of Medical Tourism in Emerging Countries
    • 9.3.3. Growing Number of Spine Surgery Centers and Hospitals
  • 9.4. Threats
    • 9.4.1. Ethical Concerns Limiting Research and Development in Spine Biologics
    • 9.4.2. Scarcity of Skilled Physicians in Emerging Countries

10. Conclusions and Recommendations

  • 10.1. Overview of the Spine Biologics Market
  • 10.2. Leading Spine Biologics Segments in 2016 and 2026
  • 10.2. Leading Spine Biologics Market by Region in 2016 and 2026
  • 10.3. Future Outlook for Spine Biologics Market
  • Visiongain Report Evaluation Form
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain Report Evaluation Form

List of Tables

  • Table 1.1: (Sample) Global Spine Biologics Market by Region: Market Forecast ($m), AGR (%), CAGR (%), 2014-2020
  • Table 3.1: Global Spine Biologics Market Forecast ($m), AGR(%),CAGR(%), 2014-2020
  • Table 3.2: Global Spine Biologics Market Forecast ($m), AGR(%),CAGR(%), 2020-2026
  • Table 3.3: Global Spine Biologics Market Drivers & Restraints, 2016
  • Table 4.1: DBM Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
  • Table 4.2: BMP/Growth Factors Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
  • Table 4.3: Bone Substitutes Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
  • Table 4.4: Cell Based Matrices Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
  • Table 4.5: Machined Bone Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
  • Table 4.6: Allograft Bone Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
  • Table 4.7: Platelet Concentrators Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
  • Table 4.8: Other Spine Biologics Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
  • Table 5.1: Spine Biologics Market by Type of Surgery: Market Forecast ($m), AGR(%),CAGR(%), 2014-2020
  • Table 5.2: Spine Biologics Market by Type of Surgery: Market Forecast ($m), AGR(%),CAGR(%), 2020-2026
  • Table 5.3: Traditional Fusion Market Forecast ($m), AGR(%),CAGR(%), 2016-2026
  • Table 5.4: Interbody Fusion Market Forecast ($m), AGR(%), CAGR(%), 2016-2026
  • Table 6.1: Spine Biologics Market by End User: Market Forecast ($m), AGR(%), CAGR(%), 2014-2020
  • Table 6.2: Spine Biologics Market by End User: Market Forecast ($m), AGR(%), CAGR(%), 2020-2026
  • Table 6.3: Inpatient Surgery Spine Centers Market Forecast ($m), AGR(%), CAGR(%), 2016-2026
  • Table 6.4: Outpatient Surgery Spine Centers Market Forecast ($m), AGR(%), CAGR(%), 2016-2026
  • Table 7.1: World Spine Biologics Market by Region: Revenues ($m) and Market Share (%), 2015 and 2016
  • Table 7.2: Global Spine Biologics Market by Region: Market Forecast ($m), AGR(%), CAGR(%), 2014-2020
  • Table 7.3: Global Spine Biologics Market by Region: Market Forecast ($m), AGR(%), CAGR(%), 2020-2026
  • Table 7.4: North America Spine Biologics Market: Revenues ($m) and Market Share (%), 2015 and 2016
  • Table 7.5: North America Spine Biologics Market: Market Forecast ($m), AGR(%), CAGR(%), 2014-2020
  • Table 7.6: North America Spine Biologics Market: Market Forecast ($m), AGR(%), CAGR(%), 2020-2026
  • Table 7.7: Europe Spine Biologics Market: Revenues ($m) and Market Share (%), 2015 and 2016
  • Table 7.8: Europe Spine Biologics Market: Market Forecast ($m), AGR(%), CAGR(%), 2014-2020
  • Table 7.9: Europe Spine Biologics Market: Market Forecast ($m), AGR(%), CAGR(%), 2020-2026
  • Table 7.10: Asia-Pacific Spine Biologics Market: Revenues ($m) and Market Share (%), 2015 and 2016
  • Table 7.11: Asia-Pacific Spine Biologics Market: Market Forecast ($m), AGR(%), CAGR(%), 2014-2020
  • Table 7.12: Asia-Pacific Spine Biologics Market: Market Forecast ($m), AGR(%), CAGR(%), 2020-2026
  • Table 8.1: Medtronic ($m, 2011-2015)
  • Table 8.2: Medtronic plc: Revenue by Business Segment ($m), 2014-2015
  • Table 8.3: Medtronic plc: Revenue by Geographic Segment ($m), 2014-2015
  • Table 8.4: SeaSpine Holdings Corporation ($m, 2012-2015)
  • Table 8.5: SeaSpine Holdings Corporation: Revenue by Business Segment ($m), 2014-2015
  • Table 8.6: SeaSpine Holdings Corporation: Revenue by Geographic Segment ($m), 2014-2015
  • Table 8.7: JOHNSON & JOHNSON ($m, 2011-2015)
  • Table 8.8: JOHNSON & JOHNSON: Revenue by Business Segment ($m), 2014-2015
  • Table 8.9: JOHNSON & JOHNSON: Revenue by Geographic Segment ($m), 2014-2015
  • Table 8.10: Stryker Corporation ($m, 2011-2015)
  • Table 8.11: Stryker Corporation: Revenue by Business Segment, ($m, 2014-2015)
  • Table 8.12: Stryker Corporation: Revenue by Geographic Segment, ($m, 2014-2015)
  • Table 8.13: GLOBUS MEDICAL, INC. ($m, 2011-2015)
  • Table 8.14: GLOBUS MEDICAL, INC.: Revenue by Business Segment, ($m, 2014-2015)
  • Table 8.15: GLOBUS MEDICAL, INC.: Revenue by Geographic Segment, ($m, 2014-2015)
  • Table 8.16: ZIMMER BIOMET HOLDINGS, INC. ($m, 2013-2015)
  • Table 8.17: ZIMMER BIOMET HOLDINGS, INC.: Revenue by Business Segment ($m), 2014-2015
  • Table 8.18: ZIMMER BIOMET HOLDINGS, INC.: Revenue by Geographic Segment, ($m,2014-2015)
  • Table 8.19: NuVasive, Inc. ($m, 2013-2015)
  • Table 8.20: NuVasive, Inc.: Revenue by Business Segment, ($m,2014-2015)
  • Table 8.21: NuVasive, Inc.: Revenue by Geographic Segment, ($m,2014-2015)
  • Table 8.22: Alphatec Holdings, Inc.. ($m, 2011-2015)
  • Table 8.23: Alphatec Holdings, Inc.: Revenue by Geographic Segment, ($m,2014-2015)
  • Table 10.1: Global Spine Biologics: Market Forecast ($m, CAGR%), 2015, 2020 and 2026
  • Table 10.2: Global Spine Biologics Market by Type of Products : Revenues ($m) and Market Shares (%), 2015

List of Figures

  • Figure 1.1: Global Spine Biologics Market Segmentation
  • Figure 3.1: Global Spine Biologics Market Forecast ($m), AGR(%), 2015-2016
  • Figure 4.1: Spine Biologics Market Share (%) by Segment, 2020
  • Figure 4.2: Spine Biologics Market Share (%) by Segment, 2026
  • Figure 4.3: DBM Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 4.5: BMP/Growth Factors Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 4.6: Bone Substitutes Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 4.7: Cell Based Matrices Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 4.8: Machined Bone Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 4.9: Allograft Bone Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 4.10: Platelet Concentrators Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 4.11: Other Spine Biologics Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.1: Spine Biologics Market Share (%) by Segment, 2015
  • Figure 5.2: Spine Biologics Market Share (%) by Segment, 2020
  • Figure 5.3: Spine Biologics Market Share (%) by Segment, 2026
  • Figure 5.4: Traditional Fusion Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 5.5: Interbody Fusion Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.1: Spine Biologics Market Share (%)by Segment, 2015
  • Figure 6.2: Spine Biologics Market Share (%)by Segment, 2020
  • Figure 6.3: Spine Biologics Market Share (%)by Segment, 2026
  • Figure 6.4: Inpatient Surgery Spine Centers Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 6.5: Outpatient Surgery Spine Centers Market Forecast: Revenue ($m) and AGR (%), 2015-2026
  • Figure 7.1: Global Spine Biologics Market by Region: Market Size ($m), 2015 and 2016
  • Figure 7.2: US Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.3: Canada Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.4: Germany Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.5: UK Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.6: France Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.7: Italy Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.8: Spain Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.9: Russia Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.10: Rest of Europe Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.11: Asia Pacific Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.12: Japan Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.13: China Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.14: India Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.15: Australia Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.16: Rest of Asia-Pacific Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 7.17: RoW Spine Biologics Market Forecast ($m), AGR(%), 2015-2026
  • Figure 8.1: Global Spine Biologics Market Share, By Companies (% share, 2015)
  • Figure 8.2: Medtronic plc: Historical sales and net income ($m), 2011-2015
  • Figure 8.3: Medtronic plc: Revenue Share by Business Area, (%, 2015)
  • Figure 8.4: Medtronic plc: Revenue Share by Geographic Segment (%, 2015)
  • Figure 8.5: SeaSpine Holdings Corporation: Historical sales and net income ($m), 2012-2015
  • Figure 8.6: SeaSpine Holdings Corporation: Revenue Share by Business Segment (%, 2015)
  • Figure 8.7: SeaSpine Holdings Corporation: Revenue Share by Geographic Segment (%, 2015)
  • Figure 8.8: JOHNSON & JOHNSON: Historical sales and net income, 2011-2015
  • Figure 8.9: JOHNSON & JOHNSON: Revenue Share by Business Segment (%, 2015)
  • Figure 8.10: JOHNSON & JOHNSON: Revenue Share by Geographic Segment (%, 2015)
  • Figure 8.11: Stryker Corporation: Historical sales and net income, 2011-2015
  • Figure 8.12: Stryker Corporation: Revenue Share by Business Segment, (%, 2015)
  • Figure 8.13: Stryker Corporation: Revenue Share by Geographic Segment (%, 2015)
  • Figure 8.14: GLOBUS MEDICAL, INC.: Historical sales and net income ($m), 2011-2015
  • Figure 8.15: GLOBUS MEDICAL, INC.: Revenue Share by Business Segment, (%, 2015)
  • Figure 8.16: GLOBUS MEDICAL, INC.: Revenue Share by Geographic Segment (%, 2015)
  • Figure 8.17: ZIMMER BIOMET HOLDINGS, INC.: Historical sales and net income ($m), 2013-2015
  • Figure 8.18: ZIMMER BIOMET HOLDINGS, INC.: Revenue Share by Business Segment, (%, 2015)
  • Figure 8.19: ZIMMER BIOMET HOLDINGS, INC.: Revenue Share by Geographic Segment (%, 2015)
  • Figure 8.20: NuVasive, Inc.: Historical sales and net income ($m), 2013-2015
  • Figure 8.21: NuVasive, Inc.: Revenue Share by Business Segment, (%, 2015)
  • Figure 8.22: NuVasive, Inc.: Revenue Share by Geographic Segment (%, 2015)
  • Figure 8.23: Alphatec Holdings, Inc.: Historical sales and net income ($m), 2011-2015
  • Figure 8.24: Alphatec Holdings, Inc.: Revenue Share by Geographic Segment (%, 2015)
  • Figure 10.1: Global Spine Biologics: Market Forecast ($m) 2015, 2020 and 2026
  • Figure 10.2: Global Spine Biologics Market by Type of Products: 2016 ($m)
  • Figure 10.3: Global Spine Biologics Market by Type of Products: 2026 ($m)
  • Figure 10.4: Global Spine Biologics Market by Geography: 2016 ($m)
  • Figure 10.5: Global Spine Biologics Market by Geography: 2026 ($m)

Companies Listed

  • Alphatec Holdings, Inc.
  • Biomet, Inc.
  • CelgenTek Innovations Corporation
  • Chinese Academy of Sciences
  • Covidein plc
  • DePuy Synthes
  • EMA
  • FDA
  • Globus Medical, Inc.
  • Indo UK Institute of Health (IUIH)
  • Integra LifeSciences Holdings Corporation
  • Japanese Health Ministry
  • Johnson & Johnson
  • LifeNet Health
  • Medtronic plc
  • Mega Surgical
  • NuVasive, Inc.
  • Orthovita Inc.
  • Osiris Therapeutics, Inc.
  • SeaSpineHoldings, Inc.
  • Stryker Corporation
  • Therapure Biopharma
  • Transplant Technologies of Texas, Ltd.
  • Weizmann Institute of Science
  • Zimmer Biomet Holdings, Inc.
  • Zimmer, Inc.
Back to Top